Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
India's DGFT issued Notification No. 50/2025-26 on 18 December 2025 (Gazette of India, Extraordinary, Part II, Section 3(ii)), inserting a new Policy Condition No. 08 under Chapter 29 of ITC (HS) 2022, Schedule-I (Import Policy). Imports of diluted Potassium Clavulanate below a CIF value of USD 77/kg, Potassium Clavulanate (KGA) below USD 180/kg, and specified clavulanic-acid-manufacture intermediates below USD 92/kg are reclassified from "Free" to "Restricted," requiring a DGFT import authorisation before Customs clearance. The measure took immediate effect and runs until 30 November 2026. It is aimed at countering low-priced Chinese potassium-clavulanate exports and protecting Indian bulk-drug fermentation capacity (Aurobindo Pharma and other domestic API makers) amid a global potassium-clavulanate supply glut.
India's DGFT issued Notification No. 41/2025-26 on 10 October 2025, inserting a new import policy condition under Chapter 29 of ITC (HS) 2022, Schedule-I (Import Policy) for Sulfadiazine API (ITC-HS codes 29359013 and 29359090). Imports with a declared CIF value below Rs. 1,774 per kilogram are reclassified from "Free" to "Restricted," requiring a DGFT import authorisation before Customs clearance. The measure took immediate effect and runs until 30 September 2026, aimed at curbing low-priced imports — Global Trade Alert records China, France and Israel among the affected exporters — while protecting domestic API manufacturers.
India's DGFT issued Notification No. 30/2025-26 on 18 September 2025, inserting a new import policy condition under Chapter 29 of ITC (HS) 2022, Schedule-I (Import Policy) for ATS-8 — (4R-Cis)-1,1-Dimethylethyl-6- cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate (HS 2932.99), the key synthesis intermediate for Atorvastatin, a National List of Essential Medicines cholesterol-lowering statin API. Imports with a declared CIF value below USD 111/kg are reclassified from "Free" to "Restricted," requiring a DGFT import authorisation before Customs clearance. The measure took immediate effect and runs until 30 September 2026. Global Trade Alert records China, Argentina and Canada among the affected exporters; global merchant-market ATS-8 supply is concentrated among Chinese producers.